Anxiety is a biological mechanism designed to protect us from dangerous situations. A little anxiety is natural; our reaction to this emotion results in the difference between a pleasant experience and a full-blown panic attack.

People with Attention Deficit Disorder with or without hyperactivity (ADHD) struggle to focus, sit still, or restrain their impulses.

Snoezelen® is a therapeutic approach that uses multisensory experiences. It was developed in the Netherlands in the 1970s for people with developmental disabilities.

Research at the Eating Disorders Program addresses various aspects of the phenomenology, etiology, and treatment of eating disorders in the spectrum of anorexia nervosa and bulimia nervosa.

The Intellectual Handicap with Psychiatric Comorbidity Program is designed for people aged 18 to 65 who have a moderate to severe intellectual handicap accompanied by a psychiatric disorder.

Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

The Program for Dementia with Psychiatric Comorbidity (PDCP) provides superspecialized care to people of all ages who have mild to severe cognitive impairments combined with psychiatric or behavioural disorders.

The Geriatric Psychiatry Program at the Douglas Institute provides services to clients aged 65 and older and to adults younger than 65 with a geriatric profile. The program covers psychiatric diagnoses such as: mood disorders anxiety di

Tak Pan Wong studies the impact of stress on the brain and evaluates how this relates to behaviour, learning and memory.

Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.